Literature DB >> 11325969

Insulin induces suppressor of cytokine signaling-3 tyrosine phosphorylation through janus-activated kinase.

P Peraldi1, C Filloux, B Emanuelli, D J Hilton, E Van Obberghen.   

Abstract

Suppressor of cytokine signaling (SOCS) proteins were originally described as cytokine-induced molecules involved in negative feedback loops. We have shown that SOCS-3 is also a component of the insulin signaling network (). Indeed, insulin leads to SOCS-3 expression in 3T3-L1 adipocytes. Once produced, SOCS-3 binds to phosphorylated tyrosine 960 of the insulin receptor and inhibits insulin signaling. Now we show that in 3T3-L1 adipocytes and in transfected COS-7 cells insulin leads to SOCS-3 tyrosine phosphorylation. This phosphorylation takes place on Tyr(204) and is dependent upon a functional SOCS-3 SH2 domain. Purified insulin receptor directly phosphorylates SOCS-3. However, in intact cells, a mutant of the insulin receptor, IRY960F, unable to bind SOCS-3, was as efficient as the wild type insulin receptor to phosphorylate SOCS-3. Importantly, IRY960F is as potent as the wild type insulin receptor to activate janus-activated kinase (Jak) 1 and Jak2. Furthermore, expression of a dominant negative form of Jak2 inhibits insulin-induced SOCS-3 tyrosine phosphorylation. As transfected Jaks have been shown to cause SOCS-3 phosphorylation, we propose that insulin induces SOCS-3 phosphorylation through Jak activation. Our data indicate that SOCS-3 belongs to a class of tyrosine-phosphorylated insulin signaling molecules, the phosphorylation of which is not dependent upon a direct coupling with the insulin receptor but relies on the Jaks.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325969     DOI: 10.1074/jbc.M102209200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

Authors:  Lerin R Luckett-Chastain; Michael A Ihnat; Bethany M Mickle-Kawar; Randle Michael Gallucci
Journal:  J Interferon Cytokine Res       Date:  2012-02-07       Impact factor: 2.607

Review 2.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

3.  SOCS3 inhibits insulin signaling in porcine primary adipocytes.

Authors:  Shuang-Juan Yang; Cheng-Quan Xu; Jiang-Wei Wu; Gong-She Yang
Journal:  Mol Cell Biochem       Date:  2010-08-04       Impact factor: 3.396

4.  Activation of opioid mu-receptors by loperamide to improve interleukin-6-induced inhibition of insulin signals in myoblast C2C12 cells.

Authors:  T-F Tzeng; I-M Liu; J-T Cheng
Journal:  Diabetologia       Date:  2005-06-15       Impact factor: 10.122

5.  Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders.

Authors:  Arunava Ghosh; Kalipada Pahan
Journal:  J Biol Chem       Date:  2012-06-08       Impact factor: 5.157

6.  Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans.

Authors:  Alexander S Banks; Jianze Li; Lisa McKeag; Marta L Hribal; Masaki Kashiwada; Domenico Accili; Paul B Rothman
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

7.  Tumor necrosis factor-a augments lipopolysaccharide-induced suppressor of cytokine signalling 3 (SOCS-3) protein expression by preventing the degradation.

Authors:  Jargalsaikhan Dagvadorj; Yoshikazu Naiki; Gantsetseg Tumurkhuu; Abu Shadat Mohammod Noman; Imtiaz Iftakhar-E-Khuda; Takayuki Komatsu; Naoki Koide; Tomoaki Yoshida
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

Review 8.  SOCS regulation of the JAK/STAT signalling pathway.

Authors:  Ben A Croker; Hiu Kiu; Sandra E Nicholson
Journal:  Semin Cell Dev Biol       Date:  2008-07-30       Impact factor: 7.727

Review 9.  TNF-alpha and adipocyte biology.

Authors:  William P Cawthorn; Jaswinder K Sethi
Journal:  FEBS Lett       Date:  2007-11-26       Impact factor: 4.124

10.  Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.

Authors:  Shoshana Yakar; Jennifer Setser; Hong Zhao; Bethel Stannard; Martin Haluzik; Vaida Glatt; Mary L Bouxsein; John J Kopchick; Derek LeRoith
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.